TIS 0.00% 0.0¢ tissue therapies limited

bell potter target $1.20, page-16

  1. TDA
    11,411 Posts.
    lightbulb Created with Sketch. 137
    Hatchy, they wont be able to push the timing to enter the US markets because that's how long the two trials will take, more interesting is how are they going to raise the funds for the trials.

    In a better, forward looking market the figures they recently announced could be viewed/reviewed by some using DCF valuations and a steady climb in price could be seen as they hit proposed earnings targets. Though, in this type of environment/market it's certainly getting harder to see that happening.

    One must take a long term view for this stock, the true meaning of long term, not just 1 or 2 years!!


 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.